CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 5.07: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.16%
Annual Rate
CNY 0.02Paid annual
Payout Ratio
35.1%Sustainable
Last Ex-Dividend
May 22, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.88BCNY578.94M · vs all stocks (USD)
Trailing P/E
116.27xRevenue (TTM)
737.90MCNY110.11M · vs all stocks (USD)
Profit Margin
4.68%Beta
0.2220xvs all stocks
52-Week Change
31.45%vs all stocks
Market Capitalization
3.88BCNY578.94M · vs all stocks (USD)
Enterprise Value
3.92BCNY584.51M · vs all stocks (USD)
Trailing P/E
116.27xPrice to Sales (TTM)
5.26xPrice to Book (MRQ)
5.42xEnterprise to Revenue
5.31xEnterprise to EBITDA
36.73xGross Margin
70.85%Profit Margin
4.68%Operating Margin
-1.65%Return on Assets (TTM)
2.90%Return on Equity (TTM)
7.05%Revenue (TTM)
737.90MCNY110.11M · vs all stocks (USD)
Revenue per Share (TTM)
2.43CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-51.20%Gross Profit (TTM)
489.07MCNY72.98M · vs all stocks (USD)
EBITDA (TTM)
87.20MCNY13.01M · vs all stocks (USD)
Net Income (TTM)
34.55MCNY5.16M · vs all stocks (USD)
Operating Cash Flow (TTM)
41.75MCNY6.23M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-8.56MCNY-1.28M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0200CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.16%vs all stocks
Payout Ratio
35.12%Minority Interest (Equity)
72.62MCNYFY2025 · Dec 31, 2025Revenue
886.96MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
281.43MCNYFY2025 · Dec 31, 2025Gross Profit
605.52MCNYFY2025 · Dec 31, 2025Operating Income
105.56MCNY15.75M · vs all stocks (USD)
Pre-tax Income
81.15MCNYFY2025 · Dec 31, 2025Income Tax Expense
15.78MCNYFY2025 · Dec 31, 2025Net Income
65.36MCNYFY2025 · Dec 31, 2025EBIT
83.81MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
136.46MCNYFY2025 · Dec 31, 2025Research & Development
27.15MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
412.23MCNYFY2025 · Dec 31, 2025Other Operating Expenses
17.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.94MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1449CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1449CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
303.32MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
303.32MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
65.36MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-21.41MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
51.21MCNYFY2025 · Dec 31, 2025Free Cash Flow
7.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
241.04MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
65.36MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.56MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-14.53MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-43.36MCNYFY2025 · Dec 31, 2025Sale of Investments
800.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-42.56MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
35.54MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-18.05MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-14.83MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.74MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-83.72KCNYFY2025 · Dec 31, 2025Shares Outstanding
303.35MSharesUpdated Sep 20, 2026Float Shares
187.15MSharesUpdated Sep 20, 2026% Held by Insiders
40.15%vs all stocks
% Held by Institutions
2.16%vs all stocks
Total Cash (MRQ)
169.22MCNY25.25M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5580CNYUpdated Sep 20, 2026Total Debt (MRQ)
123.62MCNY18.45M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1547xCurrent Ratio (MRQ)
1.65xBook Value per Share (MRQ)
2.36CNYUpdated Sep 20, 2026Total Assets
1.39BCNY208.09M · vs all stocks (USD)
Total Current Assets
654.30MCNYFY2025 · Dec 31, 2025Total Liabilities
613.42MCNYFY2025 · Dec 31, 2025Total Non-current Assets
740.20MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
155.68MCNYFY2025 · Dec 31, 2025Total Current Liabilities
457.74MCNYFY2025 · Dec 31, 2025Cash
241.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
241.33MCNYFY2025 · Dec 31, 2025Accounts Receivable
253.46MCNYFY2025 · Dec 31, 2025Inventory
115.99MCNYFY2025 · Dec 31, 2025Accounts Payable
319.44MCNYFY2025 · Dec 31, 2025Short-term Debt
50.60MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.17MCNYFY2025 · Dec 31, 2025Long-term Debt
105.73MCNYFY2025 · Dec 31, 2025Common Stock (Book)
303.35MCNYFY2025 · Dec 31, 2025Retained Earnings
269.40MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
781.08MCNY116.55M · vs all stocks (USD)
52-Week Low
6.78CNYUpdated Sep 20, 202652-Week High
20.96CNYUpdated Sep 20, 202652-Week Change
31.45%vs all stocks
Beta
0.2220xvs all stocks
50-Day MA
14.27CNYUpdated Sep 20, 2026200-Day MA
10.46CNYUpdated Sep 20, 2026Avg 10-Day Volume
44.09MSharesUpdated Sep 20, 2026Avg 30-Day Volume
65.13MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.1100CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Growth With Volume Backing
Revenue and net income have compounded over six years, and volume has leaned up with it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.71Profit Margin: 0.05
Financial Health
Altman Z-Score 5.07: safe zoneNotable
Altman Z-Score: 5.07
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Qurient Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Newland Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Sunflower Great Health Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Yatai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
ChemoCentryx Inc
Tier 1ProductionApproval-Gated PipelineRule
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Monopar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Siglent Technologies Co., Ltd.
1 interpretationGrowth With Volume Backing
Bide Pharmatech Co. Ltd.
1 interpretationGrowth With Volume Backing
Hwatsing Technology Co., Ltd.
1 interpretationGrowth With Volume Backing